Position in NVO
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,535,422
+$253,913 QoQ
Shares Held
32,028
-8.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#428
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Roundview Capital LLC holds $44,317,424 across 9 Drug Manufacturers - General names. NVO ranks #5 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
72,050 | $18,298,538 | |
| 2 | LLY |
ELI LILLY & Co
|
8,070 | $9,679,400 | |
| 3 | ABBV |
AbbVie Inc.
|
30,467 | $7,666,715 | |
| 4 | MRK |
Merck & Co., Inc.
|
42,411 | $5,449,813 | |
| 5 | NVO |
Novo Nordisk A S
This page
|
32,028 | $1,535,422 | |
| 6 | PFE |
Pfizer Inc
|
23,438 | $564,387 | |
| 7 | NVS |
Novartis AG
|
2,707 | $424,241 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,618 | $381,329 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,535,422 | 32,028 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,281,509 | 34,871 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,852,235 | 36,404 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,174,098 | 39,180 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,555,703 | 51,517 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $3,917,735 | 56,419 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $4,708,562 | 54,738 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $5,875,151 | 49,342 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,963,285 | 48,783 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $6,391,495 | 49,778 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $5,125,637 | 49,547 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $4,585,012 | 50,418 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,229,103 | 26,133 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $4,163,102 | 26,160 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $3,397,440 | 25,103 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,451,495 | 24,606 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,081,846 | 18,683 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,088,073 | 18,803 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $2,094,064 | 18,697 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,811,036 | 18,863 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,577,975 | 18,837 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,242,820 | 18,434 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,257,300 | 18,000 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,246,476 | 17,953 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $1,162,662 | 17,756 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,112,977 | 18,488 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||